Ambu A/S (AMBU-B.CO) : juste valeur

Thèse ACCE

Ambu makes single-use endoscopes and disposable airway devices, most notably the aScope bronchoscope and the aView monitor, which hospitals use to avoid the reprocessing and cross-infection risk of reusable scopes. The structural case rests on that consumables model: a 60.1% gross margin and recurring disposable volumes that tie hospital usage to Ambu's revenue rather than one-off capital sales. The near-term question is whether the business can convert that gross margin into operating profit, since the data we have shows 0.0% operating margin and flat 0.0% revenue growth, which is either a data gap or a sign the company is not yet earning a return on its growth spend. At 40.8x trailing and 25.8x forward earnings, the market is pricing in a recovery in profitability that has not yet appeared in reported numbers. With a 35/100 score and no index membership, this is a name to examine only if the operating margin and revenue lines are confirmed as reporting artifacts rather than real stagnation.